Eli Lilly
Trade Eli Lilly 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About LLY
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies.
LLY Key Statistics
Stock Snapshot
With a market cap of 875.95B, Eli Lilly(LLY) trades at $925.92. The stock has a price-to-earnings ratio of 40.39 and currently yields dividends of 67.2%.
During the trading session on 2026-04-18, Eli Lilly(LLY) shares reached a daily high of $929.59 and a low of $910.38. At a current price of $925.92, the stock is +1.7% higher than the low and still -0.4% under the high.
Trading volume for Eli Lilly(LLY) stock has reached 3.27M, versus its average volume of 2.55M.
Over the past 52 weeks, Eli Lilly(LLY) stock has traded between a high of $1,133.95 and a low of $623.78.
Over the past 52 weeks, Eli Lilly(LLY) stock has traded between a high of $1,133.95 and a low of $623.78.
LLY News
Key Points Eli Lilly has been a growth beast, coming off an impressive year in which its revenue rose by 45%. Viking Therapeutics has an exciting GLP-1 drug i...
Key Points Eli Lilly could expand the weight loss market with its latest launch. The company should remain the leader in this niche. There are plenty of reas...
Technology Eli Lilly's Pill Lags Novo Nordisk's In First Week. Why Stock Rallied. Licensing Eli Lilly's (LLY) oral weight-loss drug, Foundayo, nabbed 1,390 pres...
Analyst ratings
83%
of 35 ratingsMore LLY News
The early success of Eli Lilly’s new GLP-1 pill is the latest signal that Americans are still eager for pills that can help them lose weight. Foundayo was appr...
Eli Lilly just released results of a clinical trial that may ease concerns about the safety of its new weight-loss pill Foundayo, which seeks to rival a similar...
The good news continues for pharmaceutical giant Eli Lilly (LLY) as its newly approved obesity pill has been found to help lower the risks of heart attacks. Cla...
Eli Lilly (NYSE:LLY) has partnered with Vasa Therapeutics to use Vasa’s proprietary AI-enabled drug discovery platform. The collaboration focuses on accelerati...
Key Points It won't come cheap, as Eli Lilly is paying $6.3 billion in up-front payments in the deal. The pharmaceutical giant is also on the hook for up to $...
The study showed that orforglipron met the primary goal of cardiovascular safety compared with insulin glargine in adults with type 2 diabetes and obesity or ov...
Eli Lilly’s late-stage study of the efficacy and safety of a treatment for type 2 diabetes has produced positive results. Mike Blake/Reuters Eli Lilly’s LLY -1...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.